Artivion, Inc. (AORT)
22.78
+0.11
(+0.49%)
USD |
NYSE |
May 21, 16:00
22.78
0.00 (0.00%)
After-Hours: 19:59
Artivion Research and Development Expense (TTM) : 33.10M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NeuroOne Medical Technologies Corp. | 5.158M |
| Edwards Lifesciences Corp. | 1.088B |
| Zimmer Biomet Holdings, Inc. | 451.40M |
| PetVivo Holdings, Inc. | 1.284M |
| INVO Fertility, Inc. | 0.7504M |